ArticleDepression and anxiety2025
The Population Based Risk of Obstructive Sleep Apnea and Psychiatric Conditions.
Article in Depression and anxiety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of C-reactive protein-triglyceride-glucose and systemic immune-inflammation indices on obstructive sleep apnea in older adults with depression.Frontiers in neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study investigates the association between obstructive sleep apnea (OSA) and the risk of developing psychiatric disorders. OSA, characterized by intermittent hypoxia and sleep fragmentation, contributes to brain damage and emotional regulation issues, which may predispose individuals to psychiatric conditions such as depression, anxiety, bipolar disorder, and schizophrenia. The research focuses on understanding the heightened risks of these disorders in OSA patients to inform clinical interventions. To assess the risk differences for psychiatric disorders in patients with OSA compared to those without OSA. Materials and Methods: The study utilized a retrospective cohort design, analyzing de-identified electronic health records (EHRs) from the TriNetX US Network. Data from 7,079,095 individuals (aged 18-65 years) were included. After exclusion (prior psychiatric disorders, circadian rhythm disorders, central sleep apnea, pregnancy, or death before index date), 368,125 OSA patients and 4,396,092 non-OSA individuals remained eligible. Following propensity score matching (PSM), 360,708 patients per group were analyzed. divided into OSA (368,125 patients) and non-OSA (4,396,092 patients) cohorts. PSM (360,708 patients per group) was applied to balance baseline characteristics. The primary outcome was the 8-year risk of newly diagnosed psychiatric disorders, analyzed using Cox proportional hazards models. Results: Patients with OSA showed significantly higher cumulative probabilities for psychiatric disorders over 8 years: depressive disorders: 27.4% in OSA patients vs. 15.8% in non-OSA patients (hazard ratio [HR]: 1.913). Anxiety disorders: 37.4% in OSA patients vs. 25.4% in non-OSA patients (HR: 1.663). Bipolar disorder: increased risk in OSA patients (HR: 1.885). Schizophrenia: minimal differences between groups (HR: 0.971). Subgroup analyses revealed that younger individuals and those with higher BMI were at greater risk for psychiatric disorders. Conclusion: OSA significantly elevates the risk of psychiatric disorders, particularly depression and anxiety. These findings emphasize the need for targeted screening and management strategies for high-risk populations, including younger and overweight individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.